SAN DIEGO, July 29, 2020 /PRNewswire/ -- Arena
Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its second
quarter 2020 financial results and provide a corporate update on
Wednesday, August 5, 2020, after the
close of the U.S. financial markets. The Company will host a
question and answer session via conference call and live webcast
with the investment community the same day at 4:30 PM ET.
Conference Call & Webcast Information
When:
Wednesday, August 5, 2020, at
4:30 PM ET
Dial-in: (877) 643-7155 (United
States) or (914) 495-8552 (International)
Conference ID: 5343486
Please join the conference call at least 15 minutes early to
register. You can access the live webcast under the investor
relations section of Arena's website. A replay of the event will be
archived for 30 days after the call.
About Arena Pharmaceuticals
ARENA
Pharmaceuticals is a team with a singular purpose – deliver
our important medicines to patients.
In a rapidly changing global market, we work with a sense of
urgency every day to understand the needs of all our stakeholders,
identify bold, sometimes disruptive, ideas to get our medicines to
patients, and relentlessly execute until it's done.
ARENA - Care More. Act Differently.
Forward-Looking Statements
Certain statements in this
press release are forward-looking statements that involve a number
of risks and uncertainties. Such forward-looking statements include
statements about Arena's position, drive, portfolio,
prioritization, financial position, team, and building of the
company. For such statements, Arena claims the protection of the
Private Securities Litigation Reform Act of 1995. Actual events or
results may differ materially from Arena's expectations. Factors
that could cause actual results to differ materially from the
forward-looking statements include those disclosed in Arena's
filings with the Securities and Exchange Commission. These
forward-looking statements represent Arena's judgment as of the
time of this release. Arena disclaims any intent or obligation to
update these forward-looking statements, other than as may be
required under applicable law.
Corporate Contact:
Megan E. Knight
Arena Pharmaceuticals, Inc.
Director, Investor Relations
mknight@arenapharm.com
858.210.3635
Arena Media Contact:
IR@arenapharm.com
858.453.7200
View original content to download
multimedia:http://www.prnewswire.com/news-releases/arena-pharmaceuticals-to-release-second-quarter-2020-financial-results-and-provide-corporate-update-on-august-5-301102504.html
SOURCE Arena Pharmaceuticals, Inc.